News

Barbara Milczarek for The World of Pharmaceutical Industry Magazine!

In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.


The beginnings of inventions in the field of biotechnology [Article on IP-Blog.pl]

Author: Barbara Milczarek, patent attorney It was already back in the 19th century when the practice Czytaj dalej

Joanna Piłka recommended in the prestigious WTR Global Leaders 2022 ranking!

World Trademark Review has announced its recommendations in the prestigious WTR Global Leaders 2022 ranking. We Czytaj dalej